A detailed history of S&T Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, S&T Bank holds 142 shares of LLY stock, worth $145,081. This represents 0.03% of its overall portfolio holdings.

Number of Shares
142
Previous 147 3.4%
Holding current value
$145,081
Previous $114,000 5.26%
% of portfolio
0.03%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$625.65 - $812.69 $3,128 - $4,063
-5 Reduced 3.4%
142 $108,000
Q2 2025

Aug 06, 2025

SELL
$713.71 - $898.95 $3,568 - $4,494
-5 Reduced 3.29%
147 $114,000
Q1 2025

May 15, 2025

BUY
$725.72 - $929.72 $15,240 - $19,524
21 Added 16.03%
152 $125,000
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $95,263 - $122,099
131 New
131 $101,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track S&T Bank Portfolio

Follow S&T Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S&T Bank, based on Form 13F filings with the SEC.

News

Stay updated on S&T Bank with notifications on news.